How can SUNRx help disproportionate share hospitals manage their 340B programs?
SUNRx’s solution makes managing 340B programs simple, cost effective and worry free for disproportionate share hospitals. For example, by enabling disproportionate share hospitals to pay the 340B price for medications for all eligible patients and employees, we can help hospitals reduce the cost of providing prescription drug benefits by up to 60%. In addition, SUNRx provides disproportionate share hospitals with a safeguard against 340B drug diversion. Ensuring that only eligible employees and patients receive medications at the 340B price is one of the greatest challenges faced by DSH outpatient pharmacies. Many DSHs unknowingly divert drugs to ineligible employees and patients every day, risking costly penalties and a loss of access to 340B discounts in the future. SUNRx automates reporting and auditing requirements, and ensures that only eligible patients and hospital employees receive 340B medications.
